N.E. Miller

14.6k citations

161 papers · 11.9k indexed · 4 hit papers · h-index 53

Impact in

Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism

Papers in

Endocrinology, Diabetes and Metabolism 98
- Diabetes, Cardiovascular Risks, and Lipoproteins 86
- Hormonal and reproductive studies 12
Cancer Research 39
- Cancer, Lipids, and Metabolism 37

Co-authors: George J. Miller Olav Helge Førde Dag S. Thelle Ole D. Μjøs B. Lewis M. Nazeem Nanjee David Crook D. Reichl
Journals: Atherosclerosis (18 papers)Journal of Lipid Research (16 papers)European Journal of Clinical Investigation (11 papers)The Lancet (9 papers)Arteriosclerosis Thrombosis and Vascular Biology (6 papers)
Partner nations: United Kingdom United States Poland

In The Last Decade

N.E. Miller

161 papers receiving 11.0k citations

Hit Papers

align trajectories log scale

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1 2000 · 523 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2000 Journal of Lipid Research
1981 BMJ
1977 The Lancet
1975 The Lancet

Peers

Countries citing papers authored by N.E. Miller

Since Specialization

Citations

This map shows the geographic impact of N.E. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.E. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.E. Miller more than expected).

Fields of papers citing papers by N.E. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.E. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.E. Miller. The network helps show where N.E. Miller may publish in the future.

Co-authorship network

The 25 scholars most cited alongside N.E. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N.E. Miller Line = papers co-authored together N.E. Miller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mechanism and Physiologic Significance of the Suppression of Cholesterol Esterification in Human Interstitial Fluid Frontiers in Pharmacology ·N.E. Miller, Waldemar L. Olszewski, CDR Angeline A. Lazarus, M. Nazeem Nanjee	2016	7
2	Mass kinetics of apolipoprotein A-I in interstitial fluid after administration of intravenous apolipoprotein A-I/lecithin discs in humans Journal of Lipid Research ·Roman Hovorka, M. Nazeem Nanjee, C. Justin Cooke, CDR Angeline A. Lazarus, Waldemar L. Olszewski, N.E. Miller	2006	11
3	Human apoA‐I/C‐III/A‐IV gene cluster transgenic rabbits: effects of a high‐cholesterol diet FEBS Letters ·D. Recalde, Nadine Baroukh, Céline Viglietta, Sergey A. Zhivetév, Alexandre Konzen, Laurent Vergnes, Josette Pidoux, M. Nazeem Nanjee, Fernando Brites, Alberto Ochoa, Yasuhiro Asai, Dang Yang Ke, N.E. Miller, L. M. Houdebine	2004	8
4	Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid Atherosclerosis ·Takeshi Kujiraoka, Hiroaki Hattori, Mayumi Ito, M. Nazeem Nanjee, Mitsuaki Ishihara, Makoto Nagano, Tadao Iwasaki, C. Justin Cooke, Waldemar L. Olszewski, Premal Nirmal, Tohru Egashira, N.E. Miller	2004	8
5	Variations in lipid and apolipoprotein concentrations in human leg lymph: effects of posture and physical exercise Atherosclerosis ·C. Justin Cooke, M. Nazeem Nanjee, Premal Nirmal, Waldemar L. Olszewski, N.E. Miller	2004	27
6	Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive Journal of Lipid Research ·Oka T, Takeshi Kujiraoka, Mayumi Ito, Tohru Egashira, Sadao Takahashi, M. Nazeem Nanjee, N.E. Miller, Jari Metso, Vesa M. Olkkonen, Christian Ehnholm, Matti Jauhiainen, Hiroaki Hattori	2000	89
7	Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1 Journal of Lipid Research ·Mohamad Navab, Susan Hama, C. Justin Cooke, G.M. Anantharamaiah, Manjula Chaddha, Linda X. Jin, Ganesamoorthy Subbanagounder, Kym F. Faull, Srinivasa T. Reddy, N.E. Miller, Alan M. Fogelman Hit paper breakdown →	2000	523
8	Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans: associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency Journal of Lipid Research ·M. Nazeem Nanjee, C. Justin Cooke, Waldemar L. Olszewski, N.E. Miller	2000	49
9	Plant monoterpenes do not raise plasma high-density-lipoprotein concentrations in humans American Journal of Clinical Nutrition ·C. Justin Cooke, M. Nazeem Nanjee, P. J. S. Dewey, Jacqueline Cooper, C. Senthamilarasi, N.E. Miller	1998	8
10	High density lipoproteins and atherosclerosis III : proceedings of the 3rd International Symposium on Plasma High Density Lipoproteins and Atherosclerosis, San Antonio, 4-6 March 1992 N.E. Miller, Alan R. Tall	1992	1
11	Pharmacological Intervention for Altering Lipid Metabolism Drugs ·N.E. Miller	1990	6
12	Hormonal determinants of apolipoprotein B,E receptor expression in human liver. Positive association of receptor expression with plasma estrone concentration in middle-aged/elderly women Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·M. Nazeem Nanjee, Donald R. Koritnik, 内藤勝人, N.E. Miller	1990	18
13	Relationship of high density lipoprotein composition to plasma lecithin: cholesterol acyltransferase concentration in men Atherosclerosis ·N.E. Miller, J. Rajput-Williams, M. Nazeem Nanjee, Leslie Samuel, J J Albers	1988	24
14	Biochemical and pathological features of a modified strain of Watanabe heritable hyperlipidaemic rabbits Atherosclerosis ·P.J. Gallagher, M. Nazeem Nanjee, Tonya Richards, W. R. Roche, N.E. Miller	1988	12
15	Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia Nucleic Acids Research ·David R. Collins, Timothy J. Knott, Richard J. Pease, Lyn M. Powell, M. Fleck, Douglas Appling, Clive R. Pullinger, Ross W. Milne, Yves L. Marcel, Steve E. Humphries, Philippa J. Talmud, June K. Lloyd, N.E. Miller, D. P. R. Muller, J. E. Scott	1988	83
16	VARIATION OF APOLIPOPROTEIN-B GENE IS ASSOCIATED WITH OBESITY, HIGH BLOOD CHOLESTEROL LEVELS, AND INCREASED RISK OF CORONARY HEART DISEASE The Lancet ·J. Rajput-Williams, S. Wallis, E.J. de Bakker, Graeme I. Bell, Timothy J. Knott, P M Sweetnam, Ling-E Zeng, N.E. Miller, Jenny Scott	1988	93
17	Clinical and metabolic aspects of high-density lipoproteins Elsevier eBooks ·N.E. Miller, G. J. Miller	1984	152
18	Hypocholesterolaemia and non-cardiovascular disease: metabolic studies on subjects with low plasma cholesterol concentrations. BMJ ·C B Marenah, Basil S. Lewis, David G. Hassall, A. La Ville, Claudio Cortese, W. D. Mitchell, K. R. Bruckdorfer, B Slavin, N.E. Miller, Peter Turner, خلود عبد العزيز عبد المشعل	1983	25
19	Lipoproteins, atherosclerosis, and coronary heart disease Elsevier eBooks ·N.E. Miller, B. Lewis	1981	61
20	Bilateral posterior dislocation of shoulders. BMJ ·N.E. Miller	1969	3

About N.E. Miller

N.E. Miller is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Clinical Biochemistry, Surgery and Biochemistry, having authored 161 papers that have together received 11.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (86 papers), Lipoproteins and Cardiovascular Health (66 papers), Cancer, Lipids, and Metabolism (37 papers), Cholesterol and Lipid Metabolism (32 papers), Lipid metabolism and disorders (23 papers), Adipokines, Inflammation, and Metabolic Diseases (15 papers), Hormonal and reproductive studies (12 papers) and Liver Disease Diagnosis and Treatment (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.1k citations), Cancer Research (1.9k citations), Surgery (5.5k citations), Clinical Biochemistry (718 citations) and Cardiology and Cardiovascular Medicine (2.2k citations). N.E. Miller has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include George J. Miller, Olav Helge Førde, Dag S. Thelle, Ole D. Μjøs, B. Lewis, M. Nazeem Nanjee, David Crook, D. Reichl, Paul J. Nestel and C. Justin Cooke. Their work appears in journals such as Atherosclerosis, Journal of Lipid Research, European Journal of Clinical Investigation, The Lancet and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact